Skip to main content
Clinical Trials/DRKS00028612
DRKS00028612
Recruiting
Phase 3

Intraoperative Antegrade Bowel Lavage for Ileostomy-Reversal vs. Standard-Ileostomy-Reversal – a prospective randomized multicenter trial - ABRIL-Trial

niversitätsklinikum Freiburg, Department Chirurgie, Klinik für Allgemein- und Viszeralchirurgie0 sites204 target enrollmentStarted: September 29, 2022Last updated:

Overview

Phase
Phase 3
Status
Recruiting
Sponsor
niversitätsklinikum Freiburg, Department Chirurgie, Klinik für Allgemein- und Viszeralchirurgie
Enrollment
204

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomized controlled study
Masking
Blinded (masking used)

Eligibility Criteria

Ages
18 Years to one (—)
Sex
All

Inclusion Criteria

  • Patient with protective loop\-ileostomy scheduled for ileostomy reversal due to benign or malign underlying disease, Patient’s age \= 18 years, Ability to understand the study and to participate in the trial examinations, ECOG\-Performance\-Status 0\-2, Written informed consent

Exclusion Criteria

  • Simultaneous colon\-, liver\-, peritoeneal\-, or multivisceral resection planned, Early stoma reversal (\<28 days after initial operation), Pregnant women and nursing mothers, Expected non\-compliance of the patient or language problems, Persons with any kind of dependency on the principal investigator or employed by the sponsor or principal investigator, Legally incapacitated persons or persons held in an institution by legal or official order

Investigators

Sponsor
niversitätsklinikum Freiburg, Department Chirurgie, Klinik für Allgemein- und Viszeralchirurgie

Similar Trials